News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
335,433 Results
Type
Article (24630)
Company Profile (38)
Press Release (310762)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (106030)
Career Advice (629)
Deals (15486)
Drug Delivery (47)
Drug Development (41070)
Employer Resources (73)
FDA (7319)
Job Trends (7162)
News (169249)
Policy (14999)
Tag
2027 Genetown Elite (1)
Academia (2061)
Accelerated approval (11)
Adcomms (23)
Allergies (60)
Alliances (24247)
ALS (79)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (134)
Approvals (7511)
Artificial intelligence (254)
Autoimmune disease (59)
Automation (15)
Bankruptcy (111)
Best Places to Work (6037)
BIOSECURE Act (16)
Biosimilars (64)
Biotechnology (23)
Bladder cancer (82)
Brain cancer (33)
Breast cancer (312)
Cancer (2584)
Cardiovascular disease (156)
Career advice (554)
Career pathing (13)
CAR-T (128)
CDC (58)
Celiac Disease (1)
Cell therapy (336)
Cervical cancer (23)
Clinical research (34072)
Collaboration (807)
Compensation (89)
Complete response letters (18)
COVID-19 (2521)
CRISPR (45)
C-suite (416)
Cystic fibrosis (66)
Data (3087)
Decentralized trials (1)
Denatured (11)
Depression (36)
Diabetes (194)
Diagnostics (3348)
Digital health (21)
Diversity (5)
Diversity, equity & inclusion (19)
Drug discovery (126)
Drug pricing (64)
Drug shortages (5)
Duchenne muscular dystrophy (79)
Earnings (49830)
Editorial (30)
Employer branding (9)
Employer resources (66)
Events (45679)
Executive appointments (446)
FDA (8842)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (5)
Frontotemporal dementia (16)
Funding (757)
Gene editing (89)
Generative AI (20)
Gene therapy (278)
GLP-1 (302)
Government (3082)
Grass and pollen (5)
Guidances (269)
Healthcare (9416)
HIV (39)
Huntington's disease (9)
IgA nephropathy (26)
Immunology and inflammation (79)
Immuno-oncology (32)
Indications (65)
Infectious disease (2765)
Inflammatory bowel disease (97)
Inflation Reduction Act (3)
Influenza (108)
Intellectual property (105)
Interviews (79)
IPO (7743)
IRA (20)
Job creations (1390)
Job search strategy (507)
JPM (21)
Kidney cancer (13)
Labor market (29)
Layoffs (183)
Leadership (11)
Legal (2541)
Liver cancer (41)
Longevity (6)
Lung cancer (352)
Lymphoma (229)
Machine learning (19)
Management (27)
Manufacturing (375)
MASH (53)
Medical device (6170)
Medtech (6192)
Mergers & acquisitions (8216)
Metabolic disorders (418)
Multiple sclerosis (85)
NASH (4)
Neurodegenerative disease (157)
Neuropsychiatric disorders (21)
Neuroscience (1527)
NextGen: Class of 2026 (2893)
Non-profit (2651)
Now hiring (15)
Obesity (175)
Opinion (131)
Ovarian cancer (100)
Pain (69)
Pancreatic cancer (106)
Parkinson's disease (155)
Partnered (16)
Patents (181)
Patient recruitment (212)
Peanut (30)
People (30579)
Pharmaceutical (14)
Pharmacy benefit managers (3)
Phase 1 (10488)
Phase 2 (14882)
Phase 3 (11691)
Pipeline (2709)
Policy (176)
Postmarket research (1370)
Preclinical (4465)
Press Release (40)
Prostate cancer (134)
Psychedelics (23)
Radiopharmaceuticals (131)
Rare diseases (353)
Real estate (2675)
Recruiting (30)
Regulatory (11632)
Reports (19)
Research institute (2185)
Resumes & cover letters (75)
Rett syndrome (6)
RNA editing (7)
RSV (80)
Schizophrenia (63)
Series A (107)
Series B (68)
Service/supplier (2)
Sickle cell disease (44)
Special edition (1)
Spinal muscular atrophy (54)
Sponsored (19)
Startups (1717)
Stomach cancer (6)
Supply chain (46)
Tariffs (37)
The Weekly (42)
Vaccines (1171)
Venture capital (38)
Weight loss (84)
Women's health (32)
Worklife (7)
Date
Today (13)
Last 7 days (265)
Last 30 days (1004)
Last 365 days (13259)
2026 (1702)
2025 (13391)
2024 (16021)
2023 (19103)
2022 (26307)
2021 (29028)
2020 (27337)
2019 (22516)
2018 (16966)
2017 (16470)
2016 (15723)
2015 (18870)
2014 (13962)
2013 (11152)
2012 (11929)
2011 (12596)
2010 (11244)
Location
Africa (463)
Alabama (60)
Alaska (4)
Arizona (112)
Arkansas (4)
Asia (22580)
Australia (4220)
California (4340)
Canada (1434)
China (567)
Colorado (230)
Connecticut (184)
Delaware (175)
Europe (49768)
Florida (762)
Georgia (181)
Hawaii (2)
Idaho (32)
Illinois (368)
India (41)
Indiana (240)
Iowa (10)
Japan (254)
Kansas (43)
Kentucky (23)
Louisiana (18)
Maine (62)
Maryland (758)
Massachusetts (3116)
Michigan (145)
Minnesota (257)
Mississippi (1)
Missouri (69)
Montana (23)
Nebraska (11)
Nevada (48)
New Hampshire (41)
New Jersey (1678)
New Mexico (10)
New York (1402)
North Carolina (610)
North Dakota (9)
Northern California (2032)
Ohio (148)
Oklahoma (10)
Oregon (12)
Pennsylvania (990)
Puerto Rico (11)
Rhode Island (14)
South America (639)
South Carolina (26)
Southern California (1827)
Tennessee (69)
Texas (748)
United States (17222)
Utah (142)
Vermont (1)
Virginia (85)
Washington D.C. (49)
Washington State (394)
West Virginia (3)
Wisconsin (57)
Wyoming (2)
335,433 Results for "international vaccine institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
December 5, 2025
·
4 min read
Vaccines
Does Vaxart Hold the Key to the Elusive Norovirus Vaccine?
Competing with giants like Takeda and Moderna, the plucky biotech believes it has unlocked a future with an easy, yearly oral vaccine.
February 17, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
January 1, 2026
·
7 min read
Legal
Court Rejects Two Moderna Defenses in mRNA Vaccine Patent Row With Arbutus
Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.
February 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
·
5 min read
Press Releases
Anixa Biosciences Receives Notice of Allowance from Mexican Institute of Industrial Property (IMPI) for Patent Covering Breast Cancer Vaccine Technology
January 28, 2026
·
5 min read
Vaccines
FDA To Provide Further Data on 10 Alleged Pediatric Deaths Linked to COVID-19 Vaccines By End of Month
Last week, Center for Biologics Evaluation and Research Director Vinay Prasad claimed in an internal memo—without providing evidence—that COVID-19 vaccines were responsible for the deaths of 10 children between 2021 and 2024.
December 4, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Sanofi Suffers Another Sales Dip for ‘Gift to Public Health’ Vaccines
Sanofi’s vaccine sales dipped 2.5% in 2025, with almost all immunization products declining. Nevertheless, CEO Paul Hudson doubled down on his support for vaccine development.
January 29, 2026
·
2 min read
·
Tristan Manalac
Vaccines
ACIP Meeting Delayed as Turbulence Rocks CDC, US Vaccine Policy
The Advisory Committee on Immunization Practices was supposed to convene next week, but that meeting has been pushed back as the CDC is once again leaderless and FDA’s double-reversal on Moderna’s flu shot highlights continued uncertainty in the vaccine space.
February 20, 2026
·
2 min read
·
Tristan Manalac
Vaccines
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg
Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.
January 23, 2026
·
2 min read
·
Tristan Manalac
1 of 33,544
Next
